-The Hindu The paid news case is no longer just about Ashok Chavan. It concerns every individual and institution opposed to the sway of money power in elections Politicians everywhere are known to indulge in doublespeak and our politicians are no exception. But some recent pronouncements of our Law Minister only show that our politicians may have very few serious rivals in this sport. Not long ago, the Minister was all praise...
More »SEARCH RESULT
Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »Has India lost the 21st century?-Avalok Langer
-Tehelka With 65 percent of the population below the age of 35, India boasts of an unparalleled generational dividend, but are we turning this potential into a disaster? Avalok Langer spots a ticking time bomb Nutrition & Health* 40% of children in India are malnourished 43% of children in the age group of 12-23 months receive full immunisation 48%+ of children are underweight 50%+ of all deaths under age 5 are related to malnutrition 45% of children...
More »What Right To Education? Failing to meet the prescribed norms, half of the existing schools will lose their recognition -Arvind Panagariya
-The Times of India The three-year compliance period for the Right to Education (RTE) Act is just over. What has the Act accomplished? Sadly, not very much that is positive. A key provision in the law abolishes board examinations and grants automatic promotion to each child to the next grade at the end of the academic year. It also requires the award of a diploma to all at the end of eight...
More »Glivec lesson for pharma: Patented drugs must be priced smartly-Kiran Mazumdar Shaw
-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...
More »